Search
Now showing items 1-10 of 20
Duchenne muscular dystrophy: alpha-dystroglycan immunoexpression in skeletal muscle and cognitive performance
(Academia Brasileira de Neurologia - ABNEURO, 2005-12-01)
The Duchenne muscular systrophy (DMD) is a muscular dystrophy with cognitive impairment present in 20-30% of the cases. In the present study, in order to study the relationship between the alpha-dystroglycan (alpha-DG) ...
Congenital muscular dystrophy. Part II: a review of pathogenesis and therapeutic perspectives
(Academia Brasileira de Neurologia - ABNEURO, 2009)
The congenital muscular dystrophies (CMDs) are a group of genetically and clinically heterogeneous hereditary myopathies with preferentially autosomal recessive inheritance, that are characterized by congenital hypotonia, ...
Congenital muscular dystrophy. Part I: a review of phenotypical and diagnostic aspects
(Academia Brasileira de Neurologia - ABNEURO, 2009)
The congenital muscular dystrophies (CMDs) are a group of genetically and clinically heterogeneous hereditary myopathies with preferentially autosomal recessive inheritance, that are characterized by congenital hypotonia, ...
Distrofia muscular de Duchenne: imunoexpressão da alfa-distroglucana na musculatura esquelética e associação com performance cognitiva.
(Universidade Federal de São Paulo (UNIFESP), 2004)
A distrofia muscular de Duchenne (DMD) é uma distrofia muscular que se expressa com déficit cognitivo em 20-30% dos casos. Apesar do cérebro destas crianças parecer normal, já foram encontradas alterações diversas, não ...
Estudo da interação in vitro do Mycobacterium leprae com a célula de Schwann: análise morfológica e avaliação da expressão de moléculas funcionais
(2009)
A hanseníase é uma doença sistêmica infecto-contagiosa crônica causada pelo patógeno intracelular obrigatório Mycobacterium leprae, que afeta principalmente a pele e nervos periféricos dos seres humanos. Apesar dos intensos ...